Everpar Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$270K Sell
1,224
-221
-15% -$61.1K 0.08% 236
2026
Q1
$427K Buy
1,445
+206
+17% +$61.2K 0.15% 148
2025
Q4
$338K Sell
1,239
-111
-8% -$30.2K 0.13% 177
2025
Q3
$365K Sell
1,350
-95
-7% -$25.8K 0.14% 165
2025
Q2
$398K Sell
1,445
-164
-10% -$44.6K 0.18% 149
2025
Q1
$427K Sell
1,609
-177
-10% -$43.7K 0.23% 122
2024
Q4
$415K Buy
1,786
+243
+16% +$55.9K 0.21% 132
2024
Q3
$340K Buy
1,543
+17
+1% +$3.52K 0.18% 169
2024
Q2
$300K Buy
1,526
+387
+34% +$80K 0.15% 191
2024
Q1
$245K Buy
+1,139
New +$239K 0.15% 202

Other funds holding CME

Everpar Advisors's CME Position: Q2 2026 in Review

Everpar Advisors reduced its CME Group (CME) stake by 15% in Q2 2026, selling an estimated $61.1K and leaving 1,224 shares worth $270K. The position accounts for 0.08% of the portfolio, ranked #236.

Everpar Advisors first reported a position in CME in Q1 2024 and has held it in 10 quarters since. The position peaked at $427K in Q1 2025. 222 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • Everpar Advisors held 1,224 shares of CME Group worth $270K as of Q2 2026.
  • Everpar Advisors sold 221 CME Group shares in Q2 2026, an estimated $61.1K.
  • CME Group made up 0.08% of Everpar Advisors's portfolio in Q2 2026, its #236 holding.
  • Everpar Advisors first reported a position in CME Group in Q1 2024 and has held it in 10 quarters since.
  • Everpar Advisors's CME Group position peaked at $427K in Q1 2025.
  • 222 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on Everpar Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.